Who Owns LPCN?

Lipocine Inc. — Institutional Ownership & 13F Holdings

$2.30

-0.01 (-0.43%)

Market Cap

$43.7M

Shares Outstanding

5,445,391

Institutional Holders

19

Total Inst. Value

$1.6M

% of Float Held

QoQ Holder Change

+3

Institutional data as of Q1 2025

New Positions

3

Closed Positions

1

Increased

9

Decreased

3

Institutional Ownership Trend

Top 10 Institutional Holders(Q1 2025)

#FundValueShares
1VANGUARD GROUP INC$719K226,276
2BlackRock, Inc.$284K89,272
3GEODE CAPITAL MANAGEMENT, LLC$186K58,834
4SUSQUEHANNA INTERNATIONAL GROUP, LLP$124K38,980
5RENAISSANCE TECHNOLOGIES LLC$119K37,510
6DIMENSIONAL FUND ADVISORS LP$79K24,935
7STATE STREET CORP$59K18,626
8NORTHERN TRUST CORP$42K13,160
9BANK OF AMERICA CORP /DE/$8K2,581
10MORGAN STANLEY$8K2,575

Biggest Buyers & Sellers This Quarter

Famous Fund Managers

Related Stocks

Frequently Asked Questions

How many institutional investors hold LPCN?

As of Q1 2025, 19 institutional investors report holding LPCN (Lipocine Inc.) in their 13F filings.

Which hedge fund owns the most LPCN?

The largest institutional holder of LPCN is VANGUARD GROUP INC with $719K in shares.

Are institutions buying or selling LPCN?

This quarter, 3 institutions opened new positions in LPCN and 1 closed their positions.

What is 13F institutional ownership?

SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.

How often is institutional ownership data updated?

13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.